Choksi Laboratories Shows Stable Financial Performance in Q1 2024, Receives 'Sell' Call from MarketsMOJO

Choksi Laboratories, a microcap company in the healthcare services industry, has recently announced its financial results for the quarter ending March 2024. The results, declared on May 29, 2024, have received a 'Sell' call from MarketsMOJO.

Despite a flat performance in the quarter, Choksi Laboratories has shown improvement in its overall score, rising from 0 to 3 in the last three months. This indicates that the company has been able to maintain a stable financial position.

One of the key factors contributing to this improvement is the company's net sales, which have been the highest in the last five quarters at Rs 11.12 crore. This also reflects a positive trend in the near term sales for Choksi Laboratories.

The company's operating profit (PBDIT) has also seen a positive trend, with the highest figure of Rs 3.48 crore in the last five quarters. This indicates that Choksi Laboratories has been able to effectively manage its operations and generate profits.

Furthermore, the profit before tax less other income (PBT) has also shown a positive trend, with the highest figure of Rs 1.23 crore in the last five quarters. This indicates that the company has been able to control its expenses and generate higher profits.

Overall, Choksi Laboratories has shown a stable financial performance in the quarter ending March 2024. However, investors should take note of the 'Sell' call from MarketsMOJO and conduct their own research before making any investment decisions.